Elevated PARP1 expression has been detected in several tumor types including breast and ovarian cancer with a further rise in triple-negative breast cancer and BRCA1- or BRCA2-mutated cancers [31, 32]. This evidence concerns the gene PARP1 and triple-negative breast carcinoma.